The National Association of Chronic Disease Directors (NACDD) is a public health association for chronic disease program directors of each state and U.S. territory. Since its founding in 1988, NACDD has been a national leader in the effort to reduce chronic diseases by mobilizing its members to advocate for preventive policies and programs, encourage knowledge sharing and develop model partnerships for health promotion through state and community-based prevention strategies.
 
Information About:    
Search:
State Advocacy DO's and DON'Ts

<< TOOLBOX TABLE OF CONTENTS  >>
 State Advocacy DO's and DON'Ts

 Planning Tools for Policy Development

 Communication and Special Event Tools

 Success Stories
 Special Advocacy Topics
 FAQs

Diabetes Council Advocacy Toolbox
Log-on. Learn. Lead.

Ever confused about the differences between "advocacy" and "lobbying?" If so, these references may be just what you need! We have a variety of presentations on advocacy and the legislative process, given by some of NACDD's top experts in this area. In addition, we feature reference materials that provide you with more detailed guidance.

  1. Diabetes Council Advocacy Workshop, 2009 Diabetes Translation Conference 

    Workshop Agenda (PDF Document)

    Ivan Lanier, Director, ADA:  Case Study Exercise
    Examples of advocacy versus lobbying activities. Exercise can be completed individually or with a group.
    Case Studies - No Answers
    Case Studies - Answers

    Lisa Meyer, Cornerstone Government Affairs:  Targeting Players: Understanding Budget, Appropriations, and Authorizing.
    Brief overview of the committees and subcommittees within Congress and their respective functions. 
    PDF Document

    Ivan Lanier, ADA:  American Diabetes Association Advocacy Priorities Update
    Brief overview of ADA's 2008 advocacy successes and 2009 federal and state lobbying efforts.
    PDF Presentation

    Trish Herrmann, MS, RD, Arizona Department of Health Services:  DPCP Advocacy Success Stories
    PDF Presentation

    Gretchen Taylor, MPH, RD, Minnesota Department of Health
    State DPCP (Minnesota) example of advocacy efforts that led to the creation of the American Indian Diabetes Prevention Task Force and funding for diabetes primary prevention.
    PDF Presentation
     

    Natasha McCoy, MPH, Director, Diabetes Prevention and Control Program Louisiana Department of Health and Hospitals:  Review of the Advocacy Toolbox
    PDF Document


  2. Advocacy by State Program Staff, March 2007 (PDF Presentation) 
    This presentation describes how state programs can coordinate efforts to educate policymakers, using advocacy, partnerships, communication tools, and understanding priorities.
    David Hoffman, MEd, Chair - NACDD Legislative and Policy Commitee
     
  3. The Legislative Process & Chronic Disease Programs (PDF Presentation) 
    Lisa Meyer - Cornerstone Government Affairs
    This PowerPoint presentation provides an overview of the congressional appropriation process.  It includes timelines and suggestions on how to move issues forward.
     
  4. Advocating for Chronic Disease Programs  (PDF Presentation)
    Fran Wheeler - NACDD
    This action-oriented PowerPoint presentation offers suggestions on how individuals can focus their congressional advocacy efforts.  It includes specific suggestions on ways to become a recognized and trusted expert.
     
  5. Guide to the ABCs of State Heart Disease and Stroke Policymaking (PDF Document)
    CDC, Division for Heart Disease and Stroke Prevention
    This guide serves as a primer on advocacy within the state legislative process.  It includes suggestions on developing, implementing, and evaluating policy at the state level.  It was developed for Heart Disease and Stroke Prevention programs, but the processes described will work for all programs.
     
  6. Advocacy for Heart Disease and Stroke Programs (MS PowerPoint Presentation)
    Fran Wheeler - NACDD
    This presentation includes an overview of the legislative process, an overview of the budget and appropriation processes, and basic rules for advocacy for both the general public and state employees. Though it was developed for Heart Disease and Stroke Program audiences, the information is general and appropriate for all chronic disease programs.